Annual Shareholders Equity
$24.47 M
-$15.78 M-39.19%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual stockholders equity is $24.47 million, with the most recent change of -$15.78 million (-39.19%) on December 31, 2023.
- During the last 3 years, CGTX annual shareholders equity has risen by +$92.66 million (+135.89%).
- CGTX annual shareholders equity is now -52.27% below its all-time high of $51.27 million, reached on December 31, 2021.
Performance
CGTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$14.48 M
-$8.53 M-37.06%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly stockholders equity is $14.48 million, with the most recent change of -$8.53 million (-37.06%) on September 30, 2024.
- Over the past year, CGTX quarterly shareholders equity has dropped by -$14.44 million (-49.93%).
- CGTX quarterly shareholders equity is now -71.76% below its all-time high of $51.27 million, reached on December 31, 2021.
Performance
CGTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CGTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.2% | -49.9% |
| 3 y3 years | +135.9% | -49.9% |
| 5 y5 years | +141.9% | -49.9% |
CGTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.3% | at low | -71.8% | at low |
| 5 y | 5-year | -52.3% | +135.9% | -71.8% | +116.7% |
| alltime | all time | -52.3% | +135.9% | -71.8% | +116.7% |
Cognition Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.48 M(-37.1%) |
| Jun 2024 | - | $23.01 M(-20.3%) |
| Mar 2024 | - | $28.86 M(+17.9%) |
| Dec 2023 | $24.47 M(-39.2%) | $24.47 M(-15.4%) |
| Sep 2023 | - | $28.93 M(-15.9%) |
| Jun 2023 | - | $34.39 M(-3.9%) |
| Mar 2023 | - | $35.78 M(-11.1%) |
| Dec 2022 | $40.25 M | $40.25 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $39.32 M(-10.4%) |
| Jun 2022 | - | $43.90 M(-9.9%) |
| Mar 2022 | - | $48.74 M(-4.9%) |
| Dec 2021 | $51.27 M(-175.2%) | $51.27 M(-159.1%) |
| Sep 2021 | - | -$86.72 M(+3.6%) |
| Jun 2021 | - | -$83.68 M(+23.3%) |
| Mar 2021 | - | -$67.85 M(-0.5%) |
| Dec 2020 | -$68.18 M(+16.7%) | -$68.18 M |
| Dec 2019 | -$58.42 M | - |
FAQ
- What is Cognition Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cognition Therapeutics?
- What is Cognition Therapeutics annual shareholders equity year-on-year change?
- What is Cognition Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly shareholders equity year-on-year change?
What is Cognition Therapeutics annual stockholders equity?
The current annual shareholders equity of CGTX is $24.47 M
What is the all time high annual shareholders equity for Cognition Therapeutics?
Cognition Therapeutics all-time high annual stockholders equity is $51.27 M
What is Cognition Therapeutics annual shareholders equity year-on-year change?
Over the past year, CGTX annual stockholders equity has changed by -$15.78 M (-39.19%)
What is Cognition Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CGTX is $14.48 M
What is the all time high quarterly shareholders equity for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly stockholders equity is $51.27 M
What is Cognition Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CGTX quarterly stockholders equity has changed by -$14.44 M (-49.93%)